As mentioned, BCR-ABL1-induced PSGL-1 downregulation dampens leukemic cell engraftment in CML and presumably does not accelerate the BCR-ABL1-induced transformation process. The gene discussed is SELPLG; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.